U.S. Patent Office confirms validity of Osteotech’s U.S. patent on mixtures of a radiolucent material (News-Medical-Net)
U.S. Patent Office confirms validity of Osteotech’s U.S. patent on mixtures of a radiolucent material (News-Medical-Net)
Osteotech, Inc. ( NASDAQ:OSTE ) , a leader in the emerging field of biologic solutions for regenerative medicine, announced today that the United States Patent and Trademark Office has confirmed the validity of its U.S. Patent No. 5,676,146.
Categories: Patents Tags:
Cereplast Granted European Formulation Patent (InfoBolsa)
Cereplast Granted European Formulation Patent (InfoBolsa)
24/03/2008 13:00:00 Business Wire US8668101046 Cereplast, Inc. (OTCBB:CERP), developer and manufacturer of proprietary, bio-based, sustainable bioplastics, secured additional patent protection for the Cereplast Compostables(TM) Resin family of products from the European Patent Office.
Categories: Patents Tags: